Publications by authors named "Joe Yang"

Claim this Profile
C
Correction: Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison.
Surya P Bhatt, Nick Freemantle, Mena Soliman, Jigna Heble, Yann Cabon, Joe Yang

Pulm Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison.
Surya P Bhatt, Nick Freemantle, Mena Soliman, Jigna Heble, Yann Cabon, Joe Yang

Pulm Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis Using Natural Language Processing.
Jordan Guillot, Christopher Y K Williams, Shadera Azzam, Balu Bhasuran, Gail Fernandes, Joe Yang

Gastro Hep Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning system for true- and pseudo-invasion in colorectal polyps.
Joe Yang, Lina Chen, Eric Liu, Boyu Wang, David K Driman

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Martina Paoletti, Andrea Marcellusi, Joe Yang, Francesco Saverio Mennini

Glob Reg Health Technol Assess· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States.
Zobair M Younossi, James M Paik, Linda Henry, Joe Yang, Gail Fernandes

J Clin Exp Hepatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
Joe Yang, Jaesh Naik, Matthew Massello, Lewis Ralph, Ryan James Dillon

Infect Dis Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
Joe Yang, Jaesh Naik, Matthew Massello, Lewis Ralph, Ryan James Dillon

Infect Dis Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France.
Teddy Linet, Laurie Lévy-Bachelot, Gaëlle Farge, Simone Crespi, Joe Z Yang

Eur J Contracept Reprod Health Care· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective.
Adnan Alsumali, Roy F Chemaly, Jonathan Graham, Yiling Jiang, Sanjay Merchant, Joe Yang

J Med Virol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Jaesh Naik, Laura Puzniak, Simone Critchlow, David Elsea, Ryan James Dillon, Joe Yang

Infect Dis Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial.
Thomas Lodise, Joe Yang, Laura A Puzniak, Ryan Dillon, Marin Kollef

Infect Dis Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis